entertainment -WSS

entertainment

author：focus 2025-10-01 05:38:39 - browse：593

A team of high-powered scientists and billionaire investors said Friday that they’re launching a biomedical institute in Cambridge’s Kendall Square with $500 million in private funding with the aim of shortening the path from research breakthroughs to life-saving medicines.

The institute, called Arena BioWorks, will put drug discovery and company creation under one roof, upending the traditional model where academic research and venture-backed drug development are separate.

Backed by deep-pocketed investors including Steve Pagliuca, the former co-chair of Bain Capital and Celtics co-owner, and high-tech mogul Michael Dell, Arena has already lured top scientists from academic labs with lucrative compensation packages, but so far has publicly named only a few.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Continuity nursing helped my family in our darkest PICU moments
Next article： As billionaires fund anti

explore

WSS

Novo Nordisk touts Wegovy study, but still struggling with supply

Sweeping indictment could be Trump's biggest legal challenge yet: ANALYSIS

Class action alleges UnitedHealth concealed DOJ probe

Mark Cuban is blaming the wrong people for high drug costs

Biden administration begins canceling student loan debt for 804,000 borrowers

Maui wildfire now ranks as the fifth

focus

entertainment

knowledge

Walensky prepares to leave CDC — and Congress — behind

Lawmakers grill UnitedHealth CEO on Change cyberattack

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

Schizophrenia gene found to be linked to cells' energy dysfunction

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

Deliver public health messages at the right time

Hepatitis C has a cure — but many Americans still lack access to it

Senators push IRS to launch nonprofit hospital probe

Activists slam private health insurers over coverage restrictions

Has Bernie Sanders reached the limit of his pharma bullying effort?

leisure time

Brain MRIs reveal impact of 'toxic stress' on Black children

Most antidepressants don't work on kids, teens, study finds

Illumina slashes 2023 revenue projections yet again

Surge in Apellis stock fueled by confidence in safety of its eye drug

After Optum profits sink, UnitedHealth makes changes

HHS's proposed rule does nothing to address the climate crisis

hotspot

explore

focus

entertainment